Skip to main content
. 2017 Jul 25;61(8):e00776-17. doi: 10.1128/AAC.00776-17

FIG 7.

FIG 7

Cytotoxicity of CLP-4. The cell viability of oral fibroblasts (HEPM) treated with CLP-4 for 24, 48, and 72 h at concentrations of 0 to 256 μg/ml was determined using the CellTiter-Glo luminescent cell viability assay. Doxorubicin (10 μM) was included as a positive control. The results shown are the average of three biological replicates and standard deviations from three independent experiments. *, P < 0.05; ***, P < 0.001 compared to untreated control.